Moderna Settles Patent Dispute with Roivant for Up to $2.25 Billion
Moderna has settled a patent lawsuit with Roivant for up to $2.25 billion, ending a major legal dispute. This settlement comes amidst broader efforts to lower drug costs and could influence future vaccine development and pricing.
· 93d ago
